In brief
Scientists develop a universal antivenom to treat snake bites, revolutionizing traditional methods through an extraordinary study involving snakebite survivor Tim Friede.
A US man named Tim Friede, who has endured over 200 snake bites and injected himself with venom for nearly two decades, has inadvertently contributed to the development of a groundbreaking antivenom. Researchers discovered that his blood contains unique antibodies capable of neutralizing venom from various snake species, presenting an "unparalleled" opportunity for creating a universal antivenom. Unlike current antivenoms that target specific snake species, this innovative treatment seeks to combat snakebites - which claim around 14,000 lives annually - by targeting broader classes of toxins. Friede's initial goal was to build immunity for handling snakes, but he soon turned his efforts towards developing therapies to help others, especially those far from medical care. Dr. Jacob Glanville, who is leading the research, approached Friede to study his blood and found broadly neutralizing antibodies that can protect against multiple types of neurotoxic venom. Animal tests showed promising results, with mice surviving bites from 13 of the 19 most dangerous snake species. While there is still work to be done before this revolutionary antivenom can be tested on humans, it may eventually lead to a single treatment for both elapid and viper snake bites. Friede’s journey evolves into a beacon of hope for snakebite victims worldwide. "I'm doing something good for humanity," he said, proudly reflecting on his contribution to science.
